Integration of diagnostic information US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Integration of diagnostic information. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Integration of diagnostic information US Medical PG Question 1: Group of 100 medical students took an end of the year exam. The mean score on the exam was 70%, with a standard deviation of 25%. The professor states that a student's score must be within the 95% confidence interval of the mean to pass the exam. Which of the following is the minimum score a student can have to pass the exam?
- A. 45%
- B. 63.75%
- C. 67.5%
- D. 20%
- E. 65% (Correct Answer)
Integration of diagnostic information Explanation: ***65%***
- To find the **95% confidence interval (CI) of the mean**, we use the formula: Mean ± (Z-score × Standard Error). For a 95% CI, the Z-score is approximately **1.96**.
- The **Standard Error (SE)** is calculated as SD/√n, where n is the sample size (100 students). So, SE = 25%/√100 = 25%/10 = **2.5%**.
- The 95% CI is 70% ± (1.96 × 2.5%) = 70% ± 4.9%. The lower bound is 70% - 4.9% = **65.1%**, which rounds to **65%** as the minimum passing score.
*45%*
- This value is significantly lower than the calculated lower bound of the 95% confidence interval (approximately 65.1%).
- It would represent a score far outside the defined passing range.
*63.75%*
- This value falls below the calculated lower bound of the 95% confidence interval (approximately 65.1%).
- While close, this score would not meet the professor's criterion for passing.
*67.5%*
- This value is within the 95% confidence interval (65.1% to 74.9%) but is **not the minimum score**.
- Lower scores within the interval would still qualify as passing.
*20%*
- This score is extremely low and falls significantly outside the 95% confidence interval for a mean of 70%.
- It would indicate performance far below the defined passing threshold.
Integration of diagnostic information US Medical PG Question 2: A 26-year-old medical student comes to the physician with a 3-week history of night sweats and myalgias. During this time, he has also had a 3.6-kg (8-lb) weight loss. He returned from a 6-month tropical medicine rotation in Cambodia 1 month ago. A chest x-ray (CXR) shows reticulonodular opacities suggestive of active tuberculosis (TB). The student is curious about his likelihood of having active TB. He reads a study that compares sputum testing results between 2,800 patients with likely active TB on a basis of history, clinical symptoms, and CXR pattern and 2,400 controls. The results are shown:
Sputum testing positive for TB Sputum testing negative for TB Total
Active TB likely on basis of history, clinical symptoms, and CXR pattern 700 2100 2,800
Active TB not likely on basis of history, clinical symptoms, and CXR pattern 300 2100 2,400
Total 1000 4200 5,200
Which of the following values reflects the probability that a patient with a diagnosis of active TB on the basis of history, clinical symptoms, and CXR pattern actually has active TB?
- A. 1.4
- B. 0.50
- C. 0.70
- D. 0.88
- E. 0.25 (Correct Answer)
Integration of diagnostic information Explanation: ***0.25***
- This value represents the **positive predictive value (PPV)** for active TB based on the initial clinical assessment criteria (history, symptoms, CXR).
- PPV is calculated as the number of true positives (700) divided by the total number of individuals with a positive clinical diagnosis (700 + 2100 = 2800). So, 700 / 2800 = 0.25.
- **This answers the question**: the probability that someone with a clinical diagnosis of active TB actually has the disease.
*Incorrect 1.4*
- This value is not a valid probability, as probabilities must be between 0 and 1.0.
- It might arise from an incorrect calculation or misinterpretation of the provided data.
*Incorrect 0.50*
- This value does not correspond to any standard diagnostic metric calculated from the provided data.
- The actual prevalence of TB (based on positive sputum) is 1000/5200 = 0.19, not 0.50.
- This is likely a distractor with no meaningful interpretation in this context.
*Incorrect 0.70*
- This value represents the **sensitivity** of the sputum test for detecting active TB.
- Sensitivity is calculated as true positives (700) divided by total with disease (700 + 300 = 1000). So, 700 / 1000 = 0.70.
- Sensitivity tells us how good the test is at detecting disease when present, not the probability of having disease given a positive clinical diagnosis.
*Incorrect 0.88*
- This value represents the **specificity** of the clinical assessment.
- Specificity is calculated as true negatives (2100) divided by total without disease (2100 + 300 = 2400). So, 2100 / 2400 = 0.875 ≈ 0.88.
- Specificity tells us how good the assessment is at ruling out disease in those without it, not the probability of disease given a positive assessment.
Integration of diagnostic information US Medical PG Question 3: You are developing a new diagnostic test to identify patients with disease X. Of 100 patients tested with the gold standard test, 10% tested positive. Of those that tested positive, the experimental test was positive for 90% of those patients. The specificity of the experimental test is 20%. What is the positive predictive value of this new test?
- A. 10%
- B. 90%
- C. 95%
- D. 11% (Correct Answer)
- E. 20%
Integration of diagnostic information Explanation: ***11%***
- The positive predictive value (PPV) is calculated as **true positives / (true positives + false positives)**.
- From 100 patients, 10 have disease (prevalence 10%). With 90% sensitivity, the test correctly identifies **9 true positives** (90% of 10).
- Of 90 patients without disease, specificity of 20% means 20% are correctly identified as negative (18 true negatives), so **72 false positives** = 90 × (1 - 0.20).
- Therefore, PPV = 9 / (9 + 72) = 9/81 = **11.1% ≈ 11%**.
*10%*
- This value represents the **prevalence** of the disease in the population, not the positive predictive value of the test.
- Prevalence is the proportion of individuals who have the disease (10 out of 100 patients).
*90%*
- This figure represents the **sensitivity** of the test, which is the percentage of true positives correctly identified by the experimental test.
- Sensitivity = true positives / (true positives + false negatives) = 9/10 = 90%.
*95%*
- This value is not directly derivable from the given data and does not represent any standard test characteristic in this context.
- It would imply a much higher PPV than what can be calculated given the low specificity of 20%.
*20%*
- This is the stated **specificity** of the test, which measures the proportion of true negatives correctly identified.
- Specificity = true negatives / (true negatives + false positives) = 18/90 = 20%.
Integration of diagnostic information US Medical PG Question 4: A 57-year-old man presents to the clinic for a chronic cough over the past 4 months. The patient reports a productive yellow/green cough that is worse at night. He denies any significant precipitating event prior to his symptoms. He denies fever, chest pain, palpitations, weight changes, or abdominal pain, but endorses some difficulty breathing that waxes and wanes. He denies alcohol usage but endorses a 35 pack-year smoking history. A physical examination demonstrates mild wheezes, bibasilar crackles, and mild clubbing of his fingertips. A pulmonary function test is subsequently ordered, and partial results are shown below:
Tidal volume: 500 mL
Residual volume: 1700 mL
Expiratory reserve volume: 1500 mL
Inspiratory reserve volume: 3000 mL
What is the functional residual capacity of this patient?
- A. 4500 mL
- B. 2000 mL
- C. 2200 mL
- D. 3200 mL (Correct Answer)
- E. 3500 mL
Integration of diagnostic information Explanation: ***3200 mL***
- The **functional residual capacity (FRC)** is the volume of air remaining in the lungs after a normal expiration.
- It is calculated as the sum of the **expiratory reserve volume (ERV)** and the **residual volume (RV)**. In this case, 1500 mL (ERV) + 1700 mL (RV) = 3200 mL.
*4500 mL*
- This value represents the sum of the **inspiratory reserve volume (3000 mL)** and the **residual volume (1700 mL)**, which does not correspond to a standard lung volume or capacity.
- It does not logically relate to the definition of functional residual capacity.
*2000 mL*
- This value represents the sum of the **tidal volume (500 mL)** and the **expiratory reserve volume (1500 mL)**, which is incorrect for FRC.
- This would represent the inspiratory capacity minus the inspiratory reserve volume, which is not a standard measurement used in pulmonary function testing.
*2200 mL*
- This value could be obtained by incorrectly adding the **tidal volume (500 mL)** and the **residual volume (1700 mL)**, which is not the correct formula for FRC.
- This calculation represents a miscombination of lung volumes that does not correspond to any standard pulmonary capacity measurement.
*3500 mL*
- This value is the sum of the **tidal volume (500 mL)**, the **expiratory reserve volume (1500 mL)**, and the **residual volume (1700 mL)**.
- This would represent the FRC plus the tidal volume, which is not a standard measurement and does not represent the functional residual capacity.
Integration of diagnostic information US Medical PG Question 5: A student health coordinator plans on leading a campus-wide HIV screening program that will be free for the entire undergraduate student body. The goal is to capture as many correct HIV diagnoses as possible with the fewest false positives. The coordinator consults with the hospital to see which tests are available to use for this program. Test A has a sensitivity of 0.92 and a specificity of 0.99. Test B has a sensitivity of 0.95 and a specificity of 0.96. Test C has a sensitivity of 0.98 and a specificity of 0.93. Which of the following testing schemes should the coordinator pursue?
- A. Test A on the entire student body followed by Test B on those who are positive
- B. Test A on the entire student body followed by Test C on those who are positive
- C. Test C on the entire student body followed by Test B on those who are positive
- D. Test C on the entire student body followed by Test A on those who are positive (Correct Answer)
- E. Test B on the entire student body followed by Test A on those who are positive
Integration of diagnostic information Explanation: ***Test C on the entire student body followed by Test A on those who are positive***
- To "capture as many correct HIV diagnoses as possible" (maximize true positives), the initial screening test should have the **highest sensitivity**. Test C has the highest sensitivity (0.98).
- To "capture as few false positives as possible" (maximize true negatives and confirm diagnoses), the confirmatory test should have the **highest specificity**. Test A has the highest specificity (0.99).
*Test A on the entire student body followed by Test B on those who are positive*
- Starting with Test A (sensitivity 0.92) would miss more true positive cases than starting with Test C (sensitivity 0.98), failing the goal of **capturing as many cases as possible**.
- Following with Test B (specificity 0.96) would result in more false positives than following with Test A (specificity 0.99).
*Test A on the entire student body followed by Test C on those who are positive*
- This scheme would miss many true positive cases initially due to Test A's lower sensitivity compared to Test C.
- Following with Test C would introduce more false positives than necessary, as it has a lower specificity (0.93) than Test A (0.99).
*Test C on the entire student body followed by Test B on those who are positive*
- While Test C is a good initial screen for its high sensitivity, following it with Test B (specificity 0.96) is less optimal than Test A (specificity 0.99) for minimizing false positives in the confirmation step.
- This combination would therefore yield more false positives in the confirmatory stage than using Test A.
*Test B on the entire student body followed by Test A on those who are positive*
- Test B has a sensitivity of 0.95, which is lower than Test C's sensitivity of 0.98, meaning it would miss more true positive cases at the initial screening stage.
- While Test A provides excellent specificity for confirmation, the initial screening step is suboptimal for the goal of capturing as many diagnoses as possible.
Integration of diagnostic information US Medical PG Question 6: You submit a paper to a prestigious journal about the effects of coffee consumption on mesothelioma risk. The first reviewer lauds your clinical and scientific acumen, but expresses concern that your study does not have adequate statistical power. Statistical power refers to which of the following?
- A. The probability of detecting an association when no association exists.
- B. The probability of not detecting an association when an association does exist.
- C. The probability of detecting an association when an association does exist. (Correct Answer)
- D. The first derivative of work.
- E. The square root of the variance.
Integration of diagnostic information Explanation: ***The probability of detecting an association when an association does exist.***
- **Statistical power** is defined as the probability that a study will correctly reject a false null hypothesis, meaning it will detect a true effect or association if one exists.
- A study with **adequate statistical power** is less likely to miss a real effect.
*The probability of detecting an association when no association exists.*
- This describes a **Type I error** or **false positive**, often represented by **alpha (α)**.
- It is the probability of incorrectly concluding an effect or association exists when, in reality, there is none.
*The probability of not detecting an association when an association does exist.*
- This refers to a **Type II error** or **false negative**, represented by **beta (β)**.
- **Statistical power** is calculated as **1 - β**, so this option describes the complement of power.
*The first derivative of work.*
- The first derivative of work with respect to time represents **power** in physics, which is the rate at which work is done.
- This option is a **distractor** from physics and is unrelated to statistical power in research.
*The square root of the variance.*
- The **square root of the variance** is the **standard deviation**, a measure of the dispersion or spread of data.
- This is a statistical concept but is not the definition of statistical power.
Integration of diagnostic information US Medical PG Question 7: You are reviewing raw data from a research study performed at your medical center examining the effectiveness of a novel AIDS screening examination. The study enrolled 250 patients with confirmed AIDS, and 240 of these patients demonstrated a positive screening examination. The control arm of the study enrolled 250 patients who do not have AIDS, and only 5 of these patients tested positive on the novel screening examination. What is the NPV of this novel test?
- A. 240 / (240 + 15)
- B. 240 / (240 + 5)
- C. 240 / (240 + 10)
- D. 245 / (245 + 10) (Correct Answer)
- E. 245 / (245 + 5)
Integration of diagnostic information Explanation: ***245 / (245 + 10)***
- The **negative predictive value (NPV)** is calculated as **true negatives (TN)** divided by the sum of **true negatives (TN)** and **false negatives (FN)**.
- In this study, there are 250 patients with AIDS; 240 tested positive (true positives, TP), meaning 10 tested negative (false negatives, FN = 250 - 240). There are 250 patients without AIDS; 5 tested positive (false positives, FP), meaning 245 tested negative (true negatives, TN = 250 - 5). Therefore, NPV = 245 / (245 + 10).
*240 / (240 + 15)*
- This calculation incorrectly uses the number of **true positives** (240) in the numerator and denominator, which is relevant for **positive predictive value (PPV)**, not NPV.
- The denominator `(240 + 15)` does not correspond to a valid sum for calculating NPV from the given data.
*240 / (240 + 5)*
- This calculation incorrectly uses **true positives** (240) in the numerator, which is not part of the NPV formula.
- The denominator `(240 + 5)` mixes true positives and false positives, which is incorrect for NPV.
*240 / (240 + 10)*
- This incorrectly places **true positives** (240) in the numerator instead of **true negatives**.
- The denominator `(240+10)` represents **true positives + false negatives**, which is related to sensitivity, not NPV.
*245 / (245 + 5)*
- This calculation correctly identifies **true negatives** (245) in the numerator but incorrectly uses **false positives** (5) in the denominator instead of **false negatives**.
- The denominator for NPV should be **true negatives + false negatives**, which is 245 + 10.
Integration of diagnostic information US Medical PG Question 8: A 43-year-old woman presents to the neurology clinic in significant pain. She reports a sharp, stabbing electric-like pain on the right side of her face. The pain started suddenly 2 weeks ago. The pain is so excruciating that she can no longer laugh, speak, or eat her meals as these activities cause episodes of pain. She had to miss work last week as a result. Her attacks last about 3 minutes and go away when she goes to sleep. She typically has 2–3 attacks per day now. The vital signs include: blood pressure 132/84 mm Hg, heart rate 79/min, and respiratory rate 14/min. A neurological examination shows no loss of crude touch, tactile touch, or pain sensations on the right side of the face. The pupillary light and accommodation reflexes are normal. There is no drooping of her mouth, ptosis, or anhidrosis noted. Which of the following is the most likely diagnosis?
- A. Atypical facial pain
- B. Cluster headache
- C. Trigeminal neuralgia (Correct Answer)
- D. Bell’s palsy
- E. Basilar migraine
Integration of diagnostic information Explanation: ***Trigeminal neuralgia***
- The patient's presentation of sudden, sharp, stabbing, electric-shock-like pain on one side of the face, triggered by activities like speaking, eating, and laughing, is highly characteristic of **trigeminal neuralgia**.
- The attacks are typically brief (lasting seconds to minutes), severe, and can cause significant functional impairment, consistent with the patient's report of missed work and inability to eat or speak.
*Atypical facial pain*
- This condition involves persistent, aching, or burning facial pain without clear neurological deficits, and it often does not have the paroxysmal, electric-shock quality seen in trigeminal neuralgia.
- Unlike **trigeminal neuralgia**, atypical facial pain is usually continuous rather than episodic and is not typically triggered by specific activities.
*Cluster headache*
- Characterized by severe, unilateral pain, often periorbital or temporal, accompanied by autonomic symptoms such as **lacrimation, conjunctival injection, nasal congestion, rhinorrhea, sweating, miosis, ptosis, and eyelid edema**.
- While very painful, the pain quality is usually deep and boring, not typically described as sharp, electric-shock like, and it is not triggered by facial movements like eating or speaking.
*Bell’s palsy*
- This condition involves **acute unilateral facial weakness or paralysis** due to inflammation of the facial nerve (CN VII), not pain as the primary symptom.
- While some patients may experience mild pain around the ear, the hallmark is facial muscle weakness leading to drooping of the mouth and inability to close the eye, which are absent in this patient.
*Basilar migraine*
- A rare type of migraine with aura symptoms originating from the brainstem, including **vertigo, dysarthria, tinnitus, bilateral visual symptoms, ataxia, and sometimes decreased level of consciousness**.
- While it can cause severe headache, it does not typically present with the described electric-shock-like facial pain triggered by movement, and the neurological examination did not reveal brainstem symptoms.
Integration of diagnostic information US Medical PG Question 9: A previously healthy 33-year-old woman comes to the physician because of pain and sometimes numbness in her right thigh for the past 2 months. She reports that her symptoms are worse when walking or standing and are better while sitting. Three months ago, she started going to a fitness class a couple times a week. She is 163 cm (5 ft 4 in) tall and weighs 88 kg (194 lb); BMI is 33.1 kg/m2. Her vital signs are within normal limits. Examination of the skin shows no abnormalities. Sensation to light touch is decreased over the lateral aspect of the right anterior thigh. Muscle strength is normal. Tapping the right inguinal ligament leads to increased numbness of the affected thigh. The straight leg test is negative. Which of the following is the most appropriate next step in management of this patient?
- A. Advise patient to wear looser pants (Correct Answer)
- B. Reduction of physical activity
- C. MRI of the lumbar spine
- D. X-ray of the hip
- E. Blood work for inflammatory markers
Integration of diagnostic information Explanation: ***Advise patient to wear looser pants***
- This patient presents with symptoms consistent with **meralgia paresthetica**, a condition caused by compression of the **lateral femoral cutaneous nerve (LFCN)**. Modifying clothing or belts that compress the inguinal ligament can relieve pressure on the nerve.
- Her increased weight, a recent increase in physical activity, and a positive Tinel's sign at the inguinal ligament (tapping leads to increased numbness) support this diagnosis.
*Reduction of physical activity*
- While excessive physical activity can contribute to meralgia paresthetica, simply reducing it without addressing the underlying compression might not fully resolve symptoms.
- The patient has recently increased physical activity, which could be a contributing factor, but it's not the primary or most direct intervention for nerve compression.
*MRI of the lumbar spine*
- An MRI of the lumbar spine would be considered if there were signs of **radiculopathy** or other spinal pathology, such as weakness, reflex changes, or a positive straight leg test, which are absent here.
- The symptoms are localized to the distribution of the LFCN, and the physical exam points away from a central spinal cause.
*X-ray of the hip*
- An X-ray of the hip would be indicated for suspected **hip joint pathology** or **bony abnormalities**, which are not suggested by the patient's symptoms (pain and numbness in the thigh, not hip joint pain).
- Meralgia paresthetica is a nerve entrapment syndrome, not a structural issue of the hip joint.
*Blood work for inflammatory markers*
- Inflammatory markers like **ESR** or **CRP** would be relevant if an **inflammatory arthritis**, infection, or systemic inflammatory condition was suspected, but the patient's symptoms are purely neurological and localized.
- There is no clinical evidence of inflammation, fever, or joint swelling to suggest an underlying inflammatory process.
Integration of diagnostic information US Medical PG Question 10: A 75-year-old man presents to the physician because of bloody urine, which has occurred several times over the past month. He has no dysuria, flank pain, nausea, or vomiting. He has no history of serious illness and takes no medications. He is a 40-pack-year smoker. The vital signs are within normal limits. Physical exam shows no abnormalities except generalized lung wheezing. The laboratory test results are as follows:
Urine
Blood 3+
RBC > 100/hpf
WBC 1–2/hpf
RBC casts Negative
Bacteria Not seen
Which of the following is the most appropriate diagnostic study at this time?
- A. Intravenous (IV) pyelography
- B. Computed tomography (CT) urogram
- C. Cystoscopy (Correct Answer)
- D. Chest X-ray
- E. Ureteroscopy
Integration of diagnostic information Explanation: ***Cystoscopy***
- Given the patient's age, history of **40-pack-year smoking**, and **painless gross hematuria** without signs of infection or renal disease, there is a high suspicion for **bladder cancer**.
- **Cystoscopy** is the **most appropriate initial diagnostic study** because it allows **direct visualization of the bladder mucosa** and enables **immediate biopsy** of any suspicious lesions.
- The clinical presentation (painless hematuria + smoking history + absence of upper tract symptoms) strongly suggests a **bladder origin**, making cystoscopy the highest-yield diagnostic test.
- Per **AUA guidelines**, cystoscopy is essential for all patients with gross hematuria and risk factors for urothelial malignancy.
*Intravenous (IV) pyelography*
- This older imaging modality has been **largely replaced by CT urogram** due to lower sensitivity and poorer visualization of both upper and lower urinary tract structures.
- It cannot provide direct mucosal visualization or tissue diagnosis.
*Computed tomography (CT) urogram*
- A **CT urogram** is excellent for evaluating the **upper urinary tract** (kidneys, ureters) and is typically part of a complete hematuria workup.
- However, when the clinical picture strongly suggests **bladder pathology** (as in this case), **cystoscopy is the more direct and definitive diagnostic test**.
- CT urogram would be complementary imaging but cannot replace cystoscopy for evaluating the bladder mucosa and obtaining tissue diagnosis.
- In practice, both studies are often performed, but cystoscopy is the **most appropriate initial study** for suspected bladder cancer.
*Chest X-ray*
- While the patient has **wheezing** (likely related to his smoking history), a chest X-ray does not evaluate the source of **hematuria**.
- It might be useful for staging if bladder cancer is confirmed, but it is not the appropriate diagnostic study for evaluating urinary tract bleeding.
*Ureteroscopy*
- **Ureteroscopy** is indicated for evaluating and treating lesions within the **ureters or renal pelvis**, typically after imaging suggests an upper tract abnormality.
- It is more invasive than cystoscopy and is not the first-line approach when clinical features point to a **bladder source**.
- There are no signs suggesting upper tract pathology (no flank pain, no hydronephrosis).
More Integration of diagnostic information US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
